WHO ICTRP trial
Study in Pain
CTRI/2011/12/002207 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2011/12/002207 |
|---|---|
| Public title | Study in Pain |
| Scientific title | Single Center, Open-Label, Prospective Study for Evaluation of Dosulepin Hydrochloride in the Management of Chronic Pain. - NIL |
| Primary sponsor | Abbott India Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | PMS |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: null- Chronic Pain |
| Interventions | Intervention1: Dosulepin Hydrochloride: Tablet avaialble in 50mg and 75mg Intervention2: Dosulepin Hydrochloride (Prothiaden): Tablet in 50 and 75mg Intervention3: Dosulepin Hydrochloride: Tablet - 75 mg, Once in a day,Route - Oral… |
| Registration date | May 12, 2011 |
| Target size | 63 |
| Secondary IDs | A12:837 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: